Visit Booth #3/D19-2, USA Pavilion, Hall 3, November 17–20
Carlsbad, CA— DCN Dx, a specialist in lateral flow diagnostics development, manufacturing, and IVD regulatory consulting and clinical research, will exhibit at MEDICA 2025, taking place November 17–20 in Düsseldorf, Germany.
The company will be located at Booth #3/D19-2 in the USA Pavilion, Hall 3, where attendees can meet with Patrick Vaughan, Ph.D., DCN Dx’s Chief Operating Officer [LinkedIn], and Mitzi Rettinger, DCN Dx’s Chief Revenue Officer [LinkedIn] (schedule a meeting here). Visitors will have the opportunity to learn how DCN Dx’s integrated IVD CRO services and point-of-care CDMO expertise can accelerate diagnostic development.
DCN Dx offers comprehensive services spanning the full IVD product lifecycle—from early-stage assay design through full-service clinical research and regulatory affairs. Its regulatory affairs services provide complete support for U.S. and international approvals, including regulatory strategy, submission preparation, agency interactions, trial oversight, and post-market compliance. This CRO offering ensures diagnostic developers a seamless and coordinated path to market.
Known for its deep expertise in point-of-care diagnostics and its role as a single-source CDMO-CRO partner, DCN Dx helps clients accelerate development timelines while navigating complex regulatory landscapes with confidence.
“MEDICA is one of the most important venues for connecting with global innovators in healthcare,” said Charlie Mamrak, DCN Dx’s CEO. “Having Pat Vaughan and Mitzi Rettinger, both senior members of our leadership team, on site underscores our commitment to supporting clients with both technical and strategic expertise.”
MEDICA is recognized as one of the largest medical B2B trade fairs in the world. Each year it brings together international experts across the medical industry to showcase technologies, exchange knowledge, and build collaborations that advance healthcare worldwide.
Attendees are strongly encouraged to schedule a meeting in advance to ensure dedicated time with DCN Dx leadership during the show.
To request a meeting with DCN Dx at MEDICA 2025, visit https://shorturl.at/7ZJOM.
About DCN Dx
DCN Dx, based in Carlsbad, California, specializes in lateral flow diagnostics development and manufacturing, and IVD regulatory consulting and clinical research. DCN Dx’s multidisciplinary CDMO specializes in creating tailored assay systems, consumables, and instruments for point-of-use applications, with a particular expertise in lateral flow assays. Their clinical research and regulatory services group specializes in the planning, execution, and oversight of IVD clinical trials, inclusive of clinical operations, data management, and biostatistics, and regulatory affairs services.
DCN Dx’s personalized approach to IVD product development and clinical trials has supported hundreds of programs and clients. They can oversee every stage from concept to assay development and platform integration, through clinical trials to manufacturing or only handle the aspects you request. In addition to lateral flow assays, DCN Dx’s clinical research expertise extends to any in vitro diagnostic, all with a focus on innovation, usability, and performance.
With a commitment to quality, customer satisfaction, and industry-leading expertise, DCN Dx is setting the benchmark for excellence in IVD services. To learn more about how we can support your diagnostic needs, visit dcndx.com.
